RIBOZYME AND OMICS
No. | Country | Appl. Date | Appl. No. | Title | Patent No |
---|---|---|---|---|---|
1 | KR | 2022-03-10 | 10-2022-0029918 | Construction of self-circularization RNA | 10-2442946 |
PCT | 2022-03-10 | PCT/KR2022/003377 | |||
JP | 2022-09-09 | 2022-554679 | |||
CN | 2022-09-22 | 202280003225.5 | |||
CA | 2022-09-26 | 3,178,127 | |||
AU | 2022-09-30 | 2022234607 | |||
EP | 2022-10-04 | EP22767538.6 | |||
US | 2022-10-12 | 18/045,860 | Alowance | ||
SG | 2023-07-04 | 11202305143S | |||
IL | 2023-07-05 | 304263 | |||
BR | 2023-07-21 | 11 2023 014691 7 | |||
KR | 2023-09-06 | 10-2023-0118503 | |||
KR | 2023-09-06 | 10-2023-0118437 | |||
PCT | 2023-09-06 | PCT/KR2023/013375 | |||
PCT | 2023-09-06 | PCT/KR2023/013376 | |||
2 | KR | 2021-12-31 | 10-2021-0193826 | TUMOR-TARGETING TRANS-SPLICING RIBOZYME EXPRESSING IMMUNE CHECKPOINT INHIBITOR AND USE THEREOF | 10-2471898 |
PCT | 2022-01-21 | PCT/KR2022/0010886 | |||
CN | 2023-04-21 | 202280007072.1 | |||
US | 2023-04-28 | 18/034,533 | |||
JP | 2023-05-22 | 2023-530894 | |||
CA | 2023-05-29 | 3,203,481 | |||
AU | 2023-06-07 | 2022210147 | |||
EP | 2023-07-12 | 22742867.9 | |||
3 | PCT | 2022-01-21 | PCT/KR2022/001106 | CANCER THERAPEUTIC COMBINATION COMPRISING A TUMOR-TARGETING TRANS-SPLICING RIBOZYME AND AN IMMUNE CHECKPOINT INHIBITOR | |
4 | KR | 2021-07-23 | 10-2021-0096986 | TRANS-SPLICING RIBOZYME SPECIFIC FOR RHODOPSIN TRANSCRIPT AND USES THEREOF | 10-2396200 |
US | 2021-12-30 | 17/646,244 | 11,504,388 | ||
PCT | 2021-07-23 | PCT/KR2021/009555 | |||
CN | 2022-03-23 | 202180005482.8 | |||
KR | 2022-03-25 | 10-2022-0037572 | 10-2522273 | ||
EP | 2022-04-15 | 21846099.6 | |||
JP | 2022-04-15 | 2022-522890 | 7334346 | ||
5 | KR | 2021-03-02 | 10-2021-0027335 | APOE4 RNA TARGETING TRANS-SPLICING RIBOZYME AND USE THEREOF | 10-2315736 |
US | 2022-01-12 | 17/626,656 | |||
EP | 2022-01-26 | 21760156.6 | |||
CN | 2022-01-28 | 202180004858.3 | |||
PCT | 2021-02-26 | PCT/KR2021/002443 | |||
JP | 2022-02-04 | 2022-507489 | |||
CA | 2022-08-26 | 3,173,742 | |||
AU | 2022-08-31 | 2021225696 |